All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Stage II Ovarian Cancer AJCC v6 and v7 | NCIT_C7830 | [Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)] |
| Malignant Epithelial Large Cell | NCIT_C36822 | |
| Stage III Ovarian Cancer AJCC v6 and v7 | NCIT_C7831 | [Stage III includes: T3, N0, M0. T3: Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)] |
| Reconstituted Oral Solution Dosage Form | NCIT_C68985 | [A solution that requires reconstitution with a suitable solvent, and is intended for oral administration.] |
| Oral Solution Dosage Form | NCIT_C68996 | [A solution intended for oral administration.] |
| Suspension 12 Hour Sustained Release Dosage Form | NCIT_C68986 | [A suspension designed to release active and/or inert ingredient(s) slowly so as to achieve a constant circulating concentration of the ingredient over a 12 hour time interval.] |
| Cleanser | NCIT_C68987 | [A preparation used in cleaning something.] |
| Medicated Adhesive Patch Dosage Form | NCIT_C68988 | [A solid composed of an impermeable occlusive backing, a formulation matrix in which the active and/or inert ingredient(s) are dissolved or dispersed and an adhesive layer. It is intended for external application.] |
| Skin Patch Dosage Form | NCIT_C28276 | [A patch intended for administration to the skin.] |
| Rectal Suppository Dosage Form | NCIT_C68989 | [A suppository intended for administration within the rectum.] |
| Regional Neuroblastoma | NCIT_C7836 | [A neuroblastoma confined to a specific anatomic region without evidence of dissemination.] |
| Neuroblastoma | NCIT_C3270 | [A neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.] |
| Recurrent Neuroblastoma | NCIT_C7837 | [The reemergence of neuroblastoma after a period of remission.] |
| Recurrent Primitive Neuroectodermal Tumor | NCIT_C27295 | [The reemergence of a primitive neuroectodermal tumor of the central or the peripheral nervous system after a period of remission.] |
| Stage IV Childhood Hepatocellular Carcinoma AJCC v7 | NCIT_C7838 | [Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.)] |
| Stage IV Hepatocellular Carcinoma AJCC v7 | NCIT_C90181 | [Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.)] |
| Childhood Hepatocellular Carcinoma | NCIT_C7955 | [A hepatocellular carcinoma occurring in children.] |
| Recurrent Childhood Malignant Liver Neoplasm | NCIT_C7839 | [A hepatocellular carcinoma or hepatoblastoma that occurs during childhood and has recurred after a period of remission.] |
| Recurrent Childhood Malignant Neoplasm | NCIT_C162702 | [The reemergence of a childhood malignant neoplasm after a period of remission.] |
| Childhood Malignant Liver Neoplasm | NCIT_C7708 | [A malignant neoplasm of the liver developed in childhood. Representative examples include hepatoblastoma, undifferentiated (embryonal) sarcoma, and extrarenal rhabdoid tumor.] |